Abstract
Extensive bone defects in facial maxilo region can be corrected with autogenous grafts, otherwise, the desadvantages of the therapeutics modality take the research for new bone substitutes. Considering this, the use of osteoinductor factors, as bone morphogenetic proteins (BMPs), have been an alternative. Otherwise, carriers and frameworks are essential to maintain the osteoinduction capa…